AAAAAA

   
Results: 1-8 |
Results: 8
A RANDOMIZED CLINICAL-TRIAL OF PRIMARY CHEMOTHERAPY (PC) WITH TAXOL PLUS EPIRUBICIN (TE) - V - 5-FU PLUS EPIRUBICIN PLUS CYCLOPHOSPHAMIDE (FEC) IN STAGE IIIA BREAST-CANCER - A PRELIMINARY-REPORT
Authors: MALAMOS N PAPADIAMANTIS I ANDONOPOULOS M TSIKKINIS A KOSMAS H PALLIS L KOURI E SFIKAS K
Citation: N. Malamos et al., A RANDOMIZED CLINICAL-TRIAL OF PRIMARY CHEMOTHERAPY (PC) WITH TAXOL PLUS EPIRUBICIN (TE) - V - 5-FU PLUS EPIRUBICIN PLUS CYCLOPHOSPHAMIDE (FEC) IN STAGE IIIA BREAST-CANCER - A PRELIMINARY-REPORT, European journal of cancer, 34, 1998, pp. 50-50
SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL
Authors: MAVROUDIS D MALAMOS N GIANNAKAKIS T ALEXOPOULOS A POTAMIANOU A RIGATOS G KOSMAS C SARRA E PAPADOURIS S GEORGOULIAS V
Citation: D. Mavroudis et al., SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 90-90
PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER
Authors: PANAGOS G MAVROUDIS D POTAMIANOU A MALAMOS N KOUROUSIS C KAKOLYRIS S SOUGLAKOS J SARRA E GIANNAKAKIS T GEORGOULIAS V
Citation: G. Panagos et al., PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 97-97
PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/
Authors: MALAMOS N KOSMAS C ANTONOPOULOS MJ TSIKKINIS A PALLIS L PAPADIAMANTIS J KOURI E VASILAROS S
Citation: N. Malamos et al., PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/, Annals of oncology, 9, 1998, pp. 105-105
TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL
Authors: ALEXOPOULOS A MALAMOS N GIANNAKAKIS T MAUROUDIS D PANAGOS G AGELAKI S KOSMAS C SOUGLAKOS J VARDAKIS N APOSTOLAKI F GEORGOULIAS V
Citation: A. Alexopoulos et al., TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 127-127
PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
Authors: KOSMAS C TSAVARIS N POLYZOS A SEPSAS E MALAMOS N KALOFONOS HP PANOPOULOS C ANTONOPOULOS MJ
Citation: C. Kosmas et al., PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 449-449
PREMEDICATION ONE-HOUR BEFORE THE TREATMENT WITH TAXANES
Authors: SAMELIS GF PAPACOSTAS P MALAMOS N RIGATOS S ARVANITI EV STATHOPOULOS GP
Citation: Gf. Samelis et al., PREMEDICATION ONE-HOUR BEFORE THE TREATMENT WITH TAXANES, European journal of cancer, 33, 1997, pp. 76-76
PROGNOSTIC VARIABLES IN CREEK PATIENTS WITH STAGE-II BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: FOUNTZILAS G VASILAROS S KOUKOURAS D MALAMOS N PECTASIDES D ADAMOU A NENOPOULOU E KIRIAKOU K ZOUVANI I KATSOHIS K KAPPAS A SKOPA C SEMOGLOU C FAHANTIDIS E KONSTANTARAS C VASILAKI E ECONOMOPOULOS T BACOYIANNIS H BAFALOUKOS D RAZI E POLICHRONIS A ANDROULAKIS G PAPAIOANNOU T PAVLIDIS N SKARLOS D KOSMIDIS P
Citation: G. Fountzilas et al., PROGNOSTIC VARIABLES IN CREEK PATIENTS WITH STAGE-II BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 17(6D), 1997, pp. 4681-4689
Risultati: 1-8 |